Myeong-seop Kim,Taesun Park,Taeyoung Yoon,Seung Min Yang,Hae-Sun Kim,Jun Gyu Kim
申请号：
US14923525
公开号：
US09834550B2
申请日:
2015.10.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides a compound of Formula (I) being capable of modulating the activity of histone lysine demethylase (KDM), pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament. The compound of Formula (I) acts as KDM inhibitor with marked potency, thereby having an outstanding potential for a pharmaceutical intervention of cancer and any other diseases related to KDM dysregulation.
